Amanda Boyle
Family · Hackensack, NJNPI 1184212912
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $374 and has fallen 95.3% since, to $18 in 2025.
Across 57 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$166
- Merck$124
- GSK$94
- Seagen Inc.$64
- AVEO Pharmaceuticals, Inc.$51
- Ipsen Biopharmaceuticals, Inc$45
- plus $326 from 15 others
What the payments were for
- Food & beverage$870100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 15 | $166 |
| Merck | 9 | $124 |
| GSK | 6 | $94 |
| Seagen Inc. | 4 | $64 |
| AVEO Pharmaceuticals, Inc. | 2 | $51 |
| Ipsen Biopharmaceuticals, Inc | 3 | $45 |
| Amgen | 2 | $34 |
| Incyte Corporation | 2 | $29 |
| Bayer | 1 | $29 |
| Gilead | 1 | $29 |
| AstraZeneca | 2 | $28 |
| Emmaus Medical, Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Autolus Inc | 1 | $18 |
| Genmab U.S., Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Pfizer | 1 | $14 |
| Eisai Inc. | 1 | $14 |
How this compares
$870 in reported general payments places this provider in the 70th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 18 | $370 |
| Ciprofloxacin Hcl | 13 | $95 |
Paid to pharmacies, not to this prescriber.
Other family in Hackensack
- Bianca CorsiHackensack$9K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.